
In Focus SoCal: Closer look at LATE; breast cancer awareness; 1-on-1 with Assemblymember Quirk-Silva spectruminfocus.com/section/…

Home to one of 35 #Alzheimer’s Disease #Research Centers funded by the @NIH National Institute on Aging and one of 10 California Alzheimer’s Disease Centers

In Focus SoCal: Closer look at LATE; breast cancer awareness; 1-on-1 with Assemblymember Quirk-Silva spectruminfocus.com/section/…

💙 The fight against Alzheimer’s starts with YOU! Join leading researchers, clinicians, caregivers & advocates at the 37th Annual Southern California Alzheimer’s Disease Research Conference on Sept. 25 in Irvine. 🧠 Early Bird: $100 through Aug. 24! 🎟️conference.mind.uci.edu

Stop by to chat about data, animal models, and more! #AAIC24 @Model_ad_alz @NIH

@ucimind’s Claire Butler presenting at #AAIC26 her work on the potential for reversing #Alzheimers pathology. Learn more about how her team uses @Model_ad_alz’s mouse models today at poster 289!

Register now for the 37th Annual Southern California Alzheimer's Disease Research Conference and save $25 with the $100 early bird rate! 🎉 Hear expert speakers, explore the latest ADRD research, connect with the #Alzheimers community, and more. 🔗 conference.mind.uci.edu #ENDALZ

🎉 Congratulations to UC Irvine neuroscientist Oswald Steward for being awarded the 2026 Kavli Prize in Neuroscience, one of the world’s most prestigious honors in science. @KavliPrize @UCIMedSchool @UCIBioSci 🔖 bit.ly/4uYmUtR #KavliPrize #UCIPride


Great sessions at socal #ADRC symposium - spanning microglia , fish models and tau, so important to hear novel ideas from fields outside mine to expand into #TBI ! @ucimind is at the frontier of ADRD research! Colleagues include @bill_flavin @UCIMedSchool @ucsdneurodept

Women are driving discovery at UC Irvine. From cancer care to cosmic breakthroughs, UC Irvine’s female researchers are expanding the frontiers of science. uci.edu/ #WomensHistoryMonth

Crystal Glover, PhD, associate professor at #UCIMedSchool and the Outreach, Recruitment and Engagement Core Leader @ucimind, wants you to live a long, healthy life. Learn more about how she's working to remove obstacles to healthy aging for everyone: bit.ly/3NYZ9RZ

🩸 🧠 ⏱️ What if a blood test could predict WHEN an individual would develop symptoms of Alzheimer’s disease? High plasma p-tau217 predicts greater risk for Alzheimer’s symptoms—do the plasma p-tau217 levels provide insights into WHEN symptoms might begin? We found that after a certain level, plasma p-tau217 increased consistently across individuals and allowed creation of “clock” models that could be used to estimate age at p-tau217 abnormality (nature.com/articles/s41591-0…). The age at p-tau217 abnormality was strongly associated with the age that Alzheimer’s symptoms began. Interestingly, older individuals developed symptoms more quickly after p-tau217 abnormality. These models are not yet accurate enough to be useful to individuals, but we expect they can be improved by adding additional blood biomarkers and clinical features. We have created an application to view the results (amyloid.shinyapps.io/plasma_…) and shared all our code to accelerate progress. The eventual goal is to help individuals to understand their likelihood of developing Alzheimer’s symptoms. @KellenPetersen @FNIH_Org @WashUNeurology @alzassociation #ENDALZ

Could we prevent Alzheimer's before memory loss begins? Dr. Joshua Grill explains how researchers are exploring early treatment to slow or stop brain changes associated with Alzheimer’s disease in people at higher risk. Learn more about this promising area of research ➡️ bit.ly/4k3QPMP.

Today we hosted our first Ask the Doc of 2026: Reimagining clinical trials for Alzheimer's disease with Dr. Craig Stark and Casey Vanderlip youtube.com/live/4X1kcdrQHAY… via @YouTube

A clinical trial is testing whether early treatment with the drug lecanemab, already FDA-approved for individuals with Alzheimer's, could prevent memory loss before it starts. Dr. Joshua D. Grill of @ucimind discusses the AHEAD study, which is enrolling people with normal memory but who show early brain changes linked to Alzheimer's. Results could reshape how we approach dementia prevention. Watch the full episode: bit.ly/4k3QPMP

A $50 million gift from the Quilter family & $30 million in new commitments propel @ucimind to build state-of-the-art research & care facility for Alzheimer’s & dementia. @UCIAA Charles and Ann Quilter & family made the generous contribution. 🔗 bit.ly/4rKvFXa
